News
Seattle Genetics Announces Antibody-Drug Conjugate Collaboration With Millennium Yahoo
View ArticleNews
Millennium strikes $365M deal for Seattle Genetics' cancer antibody Fierce Biotech
View ArticleNews
Seattle Genetics and Millennium Report Positive Data from Pivotal Trial of Brentuximab Vedotin (SGN-35) in Relapsed or Refractory Hodgkin Lymphoma at ASH Annual Meeting Yahoo/BusinessWire
View ArticleMillennium signs licensing pact with Sunesis Pharma
Millennium signs licensing pact with Sunesis Pharma Pharmaceutical Business Review
View ArticleSunesis posts 1Q profit on Millennium payment
Sunesis posts 1Q profit on Millennium payment Yahoo/AP
View ArticleMillennium and Seattle Genetics Announce Brentuximab Vedotin (SGN-35)...
Millennium and Seattle Genetics Announce Brentuximab Vedotin (SGN-35) Presentations at 16th Congress of the European Hematology Association Yahoo/BusinessWire
View ArticleMillennium and Seattle Genetics Present Clinical Data on ADCETRIS...
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS (Brentuximab Vedotin) in Systemic ALCL at EHA Annual Meeting Enhanced Online News
View ArticleMillennium and Seattle Genetics Present Clinical Data on ADCETRIS™...
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS™ (Brentuximab Vedotin) in Pediatric Patients at EMCC Annual Meeting Yahoo/BusinessWire
View ArticleMillennium withdraws cancer drug application
Millennium withdraws cancer drug application Bizjournals.com
View ArticleMillennium begins phase III trial evaluating MLN9708 in patients with...
Millennium begins phase III trial evaluating MLN9708 in patients with relapsed and/or refractory multiple myeloma Pharmabiz
View ArticleTakeda and Millennium Announce Positive CHMP Opinion for Conditional Approval...
Takeda and Millennium Announce Positive CHMP Opinion for Conditional Approval of Adcetris in Europe Enhanced Online News
View ArticleMillennium starts Phase 3 trial for amyloidosis
Millennium starts Phase 3 trial for amyloidosis Mass High Tech, MA
View ArticleInfinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma
Infinity Pharma Amends Millennium Deal for PI3K-Delta, Gamma Equities.com
View ArticleWatson challenges patent on cancer drug Velcade
Watson challenges patent on cancer drug Velcade Yahoo/AP
View ArticleWhich Companies Are In Michael King's Oncology Wheelhouse?
Which Companies Are In Michael King's Oncology Wheelhouse? Seeking Alpha
View Article